NIH Funding Announcements

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 9 hours 10 min ago

NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional)

Mon, 10/30/2017 - 12:11
Funding Opportunity PAR-18-030 from the NIH Guide for Grants and Contracts. The National Institute on Aging invites revision applications to ongoing NIA-supported program project (P01) awards and resubmissions of unfunded program project applications (including unfunded revision requests). The applications should address scientific areas relevant to the NIA mission. Revision applications should include expansion of (an) existing, or proposal of (a) new project or projects within a program project. Revision applications may not request support beyond the end date of the parent P01 award.
Categories: NIH-Funding

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Mon, 10/30/2017 - 12:06
Funding Opportunity PAR-18-290 from the NIH Guide for Grants and Contracts. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.
Categories: NIH-Funding

NIDDK Program Projects (P01 Clinical Trial Optional)

Mon, 10/30/2017 - 12:03
Funding Opportunity PAR-18-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated program project applications. The proposed programs should address scientific areas relevant to the NIDDK mission including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat and cure these diseases, including clinical research. A description of NIDDK scientific program areas can be found at http://www.niddk.nih.gov/about-niddk/research-areas/pages/research-areas.aspx .
Categories: NIH-Funding

Center of Excellence for Research on Complementary and Integrative Health (P01 Clinical Trial Optional)

Mon, 10/30/2017 - 11:59
Funding Opportunity PAR-18-113 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages the submission of applications that requires multi-project, synergistic collaboration between outstanding scientists that blends multiple research approaches by multi-disciplinary research teams. This Center of Excellence for Research on Complementary and Integrative Health (CERCIH) program is designed to support three or more highly meritorious projects that can offer significant scientific advantages and "synergy" that could not be achieved by supporting the same projects as individual research grants. Each CERCIH must be focused on questions of high relevance to the mission of NCCIH.
Categories: NIH-Funding

NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)

Mon, 10/30/2017 - 11:55
Funding Opportunity PAR-18-205 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. BTRCs also make their technologies available to other investigators, train members of the research community in the use of the technologies, and disseminate the technologies broadly.
Categories: NIH-Funding

Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional)

Mon, 10/30/2017 - 11:43
Funding Opportunity PAR-18-029 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias (ADRD). Specifically sought is research focusing on understanding why persons with ADRD are at increased risk to develop delirium, often with a worse prognosis compared to those without antecedent ADRD, and why patients who experience delirium are at higher risk to develop subsequent short- and/or long-term mild cognitive impairment or ADRD, often with an accelerated rate of cognitive decline compared to those without preceding delirium. Relevant research projects may focus on, but are not limited to, those that A) provide insight into possible common, sequential, causative, contributory and/or synergistic pathways underlying both ADRD and delirium, B) elucidate mechanisms that lead to the development of delirium against the background of aging and/or neurodegeneration, with particular emphasis on use of appropriate animal models, C) identify risk factors for the onset and/or progression of delirium in those with ADRD and vice versa, D) diagnose and assess one condition in the setting of the other, E) identify putative phenotypes of patients with co-existing ADRD and delirium, or F) test pharmacologic and/or non-pharmacologic strategies to prevent, treat, or reduce the impact of delirium in patients with ADRD and vice versa. Research supported by this FOA is intended to provide mechanistic insight to improve risk assessment, diagnosis, phenotyping, prevention, and management approaches for both delirium and ADRD.
Categories: NIH-Funding

Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)

Mon, 10/30/2017 - 10:24
Funding Opportunity PAR-18-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages R01 grant applications that propose to develop and implement Phase III clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and across the Alzheimer's disease (AD) spectrum from pre-symptomatic to more severe stages of disease.
Categories: NIH-Funding

Multidisciplinary Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)

Mon, 10/30/2017 - 03:02
Funding Opportunity RFA-DK-17-012 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support institutional career development programs in urological research that will assist MDs, PhDs, and MD/PhDs with an interest in benign urological disease or urological research to develop the skills necessary to initiate and sustain an independent research career in urological research. Research areas supported by this initiative must be related to the mission of the NIDDK (http://www2.niddk.nih.gov/Research/ScientificAreas/Urology/) This Funding Opportunity Announcement (FOA) allows appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary study to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.
Categories: NIH-Funding

Notice of a Pre-Application Webinar for RFA-CA-17-032, Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54)

Fri, 10/27/2017 - 12:34
Notice NOT-CA-18-013 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) - (Clinical Trials Not Allowed)

Thu, 10/26/2017 - 11:39
Funding Opportunity RFA-HL-18-026 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds underrepresented in research. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators.
Categories: NIH-Funding

Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed

Thu, 10/26/2017 - 11:31
Funding Opportunity PA-18-408 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for research awards that are focused on the use of the Osteoarthritis Initiative (OAI) database, clinical data and images. This FOA seeks to expand the use of these resources by investigators in the broader research community. The publication of this FOA to the research community indicates to investigators and peer reviewers the importance that the NIAMS and others have placed on the use of the OAI resources.
Categories: NIH-Funding

Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed

Thu, 10/26/2017 - 11:31
Funding Opportunity PA-18-409 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for research awards that are focused on the use of the Osteoarthritis Initiative (OAI) database, clinical data and images. This FOA seeks to expand the use of these resources by investigators in the broader research community. The publication of this FOA to the research community indicates to investigators and peer reviewers the importance that the NIAMS and others have placed on the use of the OAI resources.
Categories: NIH-Funding

Notice of NIDCR's participation on PAR-17-496 "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"

Thu, 10/26/2017 - 11:19
Notice NOT-DE-18-002 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of NIDCR's participation on PAR-17-464 "Research to Improve Native American Health (R21 Clinical Trials Optional)"

Thu, 10/26/2017 - 11:11
Notice NOT-DE-18-001 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NEI Announces Acceptance of Grant Applications Proposing Clinical Trials through the NIH STTR Omnibus Funding Opportunity Announcement, PA 17-303

Thu, 10/26/2017 - 09:25
Notice NOT-EY-18-002 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NEI Announces Acceptance of Grant Applications Proposing Clinical Trials through the NIH SBIR Omnibus Funding Opportunity Announcement, PA 17-302

Thu, 10/26/2017 - 09:21
Notice NOT-EY-18-001 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NIH Plans for Clinical Trial Specific Parent R01 and Parent R21 Funding Opportunity Announcements

Wed, 10/25/2017 - 13:48
Notice NOT-OD-18-010 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required

Wed, 10/25/2017 - 12:41
Funding Opportunity PAR-18-407 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports applications to develop and implement a Clinical Coordinating Center for investigator-initiated multi-site clinical trials (Phase II and beyond). Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website: http://www.nhlbi.nih.gov. This FOA will utilize a bi-phasic, milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion FOA that encourages applications for a collaborating Data Coordinating Center (PAR-16-301). The objective of the Clinical Coordinating Center application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should include plans for project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. Both a Clinical Coordinating Center (CCC) application and a collaborating Data Coordinating Center (DCC) application must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application.
Categories: NIH-Funding